Upstream Bio, Inc.
UPB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -27.1% | 65.5% | -7.7% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 95.5% | 100% | 100% | 100% |
| R&D Expenses | $33 | $38 | $26 | $22 |
| G&A Expenses | $0 | $7 | $7 | $5 |
| SG&A Expenses | $6 | $7 | $7 | $5 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $38 | $45 | $33 | $27 |
| Operating Income | -$38 | -$44 | -$32 | -$26 |
| % Margin | -5,539.4% | -4,732.9% | -5,656% | -4,293.3% |
| Other Income/Exp. Net | $4 | $4 | $5 | $5 |
| Pre-Tax Income | -$34 | -$40 | -$27 | -$21 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$34 | -$40 | -$27 | -$21 |
| % Margin | -4,941.1% | -4,265.3% | -4,818% | -3,465.3% |
| EPS | -0.63 | -0.74 | -0.51 | -0.41 |
| % Growth | 14.9% | -45.1% | -24.4% | – |
| EPS Diluted | -0.63 | -0.74 | -0.51 | -0.41 |
| Weighted Avg Shares Out | 54 | 54 | 54 | 51 |
| Weighted Avg Shares Out Dil | 54 | 54 | 54 | 51 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4 | $4 | $5 | $5 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$34 | -$44 | -$32 | -$26 |
| % Margin | -4,936.6% | -4,728.4% | -5,648.4% | -4,285.3% |